Roberto Costa

ORCID: 0000-0001-6104-9113
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Cardiac Valve Diseases and Treatments
  • Congenital Heart Disease Studies
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Function and Risk Factors
  • Atrial Fibrillation Management and Outcomes
  • Infective Endocarditis Diagnosis and Management
  • Cardiac electrophysiology and arrhythmias
  • Viral Infections and Immunology Research
  • Cardiac Structural Anomalies and Repair
  • Trypanosoma species research and implications
  • Health and Lifestyle Studies
  • Cardiac Imaging and Diagnostics
  • Heart Failure Treatment and Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Public Health in Brazil
  • Business and Management Studies
  • Congenital Diaphragmatic Hernia Studies
  • Cardiovascular and exercise physiology
  • Neurological disorders and treatments
  • Cardiovascular Issues in Pregnancy
  • Parkinson's Disease Mechanisms and Treatments
  • Mechanical Circulatory Support Devices
  • Healthcare Regulation

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2012-2024

Universidade de São Paulo
2013-2024

Instituto do Coração
2006-2024

Universitat Politècnica de València
2024

Universidade Brasil
2024

CUF Porto Hospital
2020-2021

Instituto Butantan
2020

Universidade Estadual de Campinas (UNICAMP)
2017-2020

Fundação Universitária Vida Cristã
2020

Florida State University
2020

Although routinely administered, definitive evidence for the benefits of prophylactic antibiotics before implantation permanent pacemakers and implantable cardioverter-defibrillators from a large double-blinded placebo-controlled trial is lacking. The purpose this study was to determine whether antibiotic administration reduces incidence infection related device implantation.This double blinded included 1000 consecutive patients who presented primary (Pacemaker cardioverter-defibrillators)...

10.1161/circep.108.795906 article EN Circulation Arrhythmia and Electrophysiology 2009-02-01

The number of cardiac implantable electronic device (CIED) implantations has increased over recent years. Transvenous lead extraction (TLE), as a part an overall management strategy, also been increasing, not only consequence this growth, but because increasing rates infection, failure, awareness indications for management, and development tools. Clinical research is essential understanding efficacy risks TLE.

10.1093/europace/euy050 article EN EP Europace 2018-03-16

Pacemakers, implantable cardiac defibrillators, and resynchronization therapy devices are potentially life-saving treatments for a number of conditions, but not without risk. Most concerning is the risk electronic device (CIED) infection, which associated with significant morbidity, increased hospitalizations, reduced survival, healthcare costs. Recommended preventive strategies such as administration intravenous antibiotics before implantation well recognized. Uncertainties have remained...

10.1093/europace/euz246 article EN cc-by-nc EP Europace 2019-08-20

Abstract Pacemakers, implantable cardiac defibrillators, and resynchronization therapy devices are potentially life-saving treatments for a number of conditions, but not without risk. Most concerning is the risk electronic device (CIED) infection, which associated with significant morbidity, increased hospitalizations, reduced survival, healthcare costs. Recommended preventive strategies such as administration intravenous antibiotics before implantation well recognized. Uncertainties have...

10.1093/ejcts/ezz296 article EN European Journal of Cardio-Thoracic Surgery 2019-10-12

Abstract Pacemakers, implantable cardiac defibrillators, and resynchronization therapy devices are potentially lifesaving treatments for a number of conditions but not without risk. Most concerning is the risk electronic device (CIED) infection, which associated with significant morbidity, increased hospitalizations, reduced survival, health care costs. Recommended preventive strategies such as administration intravenous antibiotics before implantation well-recognized. Uncertainties have...

10.1093/eurheartj/ehaa010 article EN European Heart Journal 2020-01-10

The incidence of venous lesions after permanent pacemaker insertion is around 45%. However, this has been based on retrospective studies in a small series; moreover, factors predicting the development these injuries have not clearly defined. aim study was to identify risk for higher upper extremity deep vein thrombosis transvenous insertion. included 229 patients and criteria were age above 12 years first implant. Exclusion pulmonary embolism, lower or thrombosis, previous use central...

10.1046/j.1460-9592.2002.01301.x article EN Pacing and Clinical Electrophysiology 2002-09-01

Objectives: We performed responsiveness comparison between the patient-reported Inflammatory Rasch-built Overall Disability Scale (I-RODS) and widely used clinician-reported Neuropathy Cause Treatment–Overall Limitation (INCAT-ONLS) in patients with Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), immunoglobulin M–monoclonal gammopathy of undetermined significance related polyneuropathy (IgM-MGUSP). Methods: One hundred thirty-seven (GBS: 55,...

10.1212/wnl.0000000000001044 article EN Neurology 2014-11-07

Cardiac implantable electronic device (CIED) infection rates are increasing. Worldwide compliance and disparities to published guidelines for the prevention, diagnosis management of these conditions not well elucidated. The purpose this survey, therefore, was clarify issues through an inquiry arrhythmia-related associations societies worldwide.A questionnaire comprising 15 questions related CIED infections distributed among members seven arrhythmia worldwide. A total 234 centres in 62...

10.1093/europace/euz137 article EN EP Europace 2019-04-18

Background The ability to apply standard and interoperable solutions for implementing managing medical registries as well aggregate, reproduce, access data sets from legacy formats platforms advanced operating systems are crucial both clinical healthcare biomedical research settings. Purpose Our study describes a reproducible, highly scalable, framework device registry implementation addressing local quality components global linking problems. Methods Results We developed involving the...

10.1371/journal.pone.0071090 article EN cc-by PLoS ONE 2013-07-25

Background: The recording of arrhythmic events (AE) in renal transplant candidates (RTCs) undergoing dialysis is limited by conventional electrocardiography.However, continuous cardiac rhythm monitoring seems to be more appropriate due automatic detection arrhythmia, but this method has not been used. Objective: We aimed investigate the incidence and predictors AE RTCs using an implantable loop recorder (ILR).Methods: A prospective observational study conducted from June 2009 January 2011...

10.5935/abc.20150106 article EN cc-by-nc Arquivos Brasileiros de Cardiologia 2015-01-01

to hemodinâmico, é fundamental na indicação do método e no sucesso da investigação [14][15][16] .Os sintomas relacionados a fatores desencadeantes deverão ser avaliados sob ação desses estímulos.Quando os forem severos, colocando em risco vida paciente, investigados regime de internação hospitalar.

10.1590/s0066-782x2002001900001 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2002-01-01

OBJETIVO: Avaliar os efeitos da estimulação atrial otimizada (EAO) (estimulação duplo-sítio atrial, freqüência acima intrínseca e algoritmo funcional específico) uso de atenolol, na prevenção fibrilação (FA) recorrente. Desfecho primário: quantificar a taxa episódios FA. Desfechos secundários: qualidade vida, avaliação sintomas específicos cardiovasculares, internações hospitalares, cardioversões elétricas farmacológicas eventos cardíacos adversos. MÉTODOS: Vinte sete pacientes com FA...

10.1590/s0066-782x2007000100001 article PT cc-by-nc Arquivos Brasileiros de Cardiologia 2007-01-01

Resumo Fundamento O cardioversor-desfibrilador implantável (CDI) pode causar níveis elevados de ansiedade e depressão, resultando em efeitos negativos na qualidade vida. Objetivos Avaliar a vida, aceitação do CDI por meio instrumentos medida padronizados identificar preditores melhores respostas para cada um dos desfechos estudados. Método Coorte prospectiva com pacientes submetidos implante inicial ou reoperação manutenção dispositivo. Os estudo incluíram: CDI. A mudança nos escores (30 180...

10.36660/abc.20230590 article PT cc-by Arquivos Brasileiros de Cardiologia 2024-01-01

O Delta do Parnaíba, com sua rica diversidade natural e cultural, é um ambiente propício à integração entre ensino, pesquisa extensão. Este artigo tem como objetivo geral analisar as contribuições da Universidade Federal Parnaíba (UFDPAR) para a sustentabilidade o desenvolvimento local, especialmente no que se refere preservação ambiental, ao manejo sustentável valorização das comunidades tradicionais. Os objetivos específicos incluem: investigar os impactos dos projetos de ambiental na...

10.51891/rease.v11i3.18404 article PT cc-by Revista Ibero-Americana de Humanidades, Ciências e Educação 2025-03-18

A utilização da tecnologia do plasma rico em fibrina (PRF) e plaquetas (PRP) tecidos tem se mostrado uma excelente terapia adjunvante no tratamento de feridas, sendo usadas globalmente, comprovadas que aceleram o processo cicatrização das lesões. Este estudo revisa a literatura sobre uso feridas crônicas, destacando seus mecanismos ação, eficácia desenvolvimento tecido granulação. pesquisa abrenge artigos publicados entre 2020 2024, selecionados nas bases dados: Biblioteca Virtual saúde...

10.54751/revistafoco.v18n5-064 article PT Revista Foco 2025-05-13

The implantable cardioverter defibrillator (ICD) is highly effective in the treatment of ventricular arrhythmias (VA) responsible for sudden cardiac death. However, probability occurrence these arrhythmic events presence cardiomyopathy remains uncertain. aim this study was to compare nonoccurrence life-threatening VA ICD recipients with Chagas' versus non-Chagas' heart disease. Over a mean follow-up 10.5 months, 53 (mean age = 50.1 years, 48 male) were evaluated. Eleven patients had disease,...

10.1111/j.1540-8159.2000.tb07058.x article EN Pacing and Clinical Electrophysiology 2000-11-01
Coming Soon ...